Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × motexafin lutetium × Sarcoma × Clear all
NCT00087191 2013-01-16

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
GastrointestinalGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡